Cardiovascular Implications of Osteoporosis Treatments: Understanding the Role of Vascular Calcification and Sclerostin Pathways - Takeaways - MDSpire

Cardiovascular Implications of Osteoporosis Treatments: Understanding the Role of Vascular Calcification and Sclerostin Pathways

  • By

  • Shuwei Weng

  • Chen Ding

  • Yuhong Shi

  • Hailin Zhang

  • Wenxiang Zhao

  • Jiang Zhu

  • Feng Peng

  • Dajun Chai

  • April 29, 2026

  • 0 min

Share

  • 1

    Osteoporosis therapies are increasingly relevant to cardiovascular medicine due to the connection between bone remodeling and vascular calcification.

  • 2

    Current evidence does not support a uniform cardiovascular effect of osteoporosis therapies; effects appear drug-specific and context-dependent.

  • 3

    Bisphosphonates and denosumab are biologically relevant to vascular calcification but lack consistent evidence for reducing coronary-specific outcomes.

  • 4

    Romosozumab shows strong anti-fracture efficacy but raises unresolved cardiovascular safety concerns linked to sclerostin inhibition.

  • 5

    The relationship between osteoporosis and coronary artery disease is complex, involving shared biological pathways and signaling systems.

Original Source(s)

Cardiovascular Implications of Osteoporosis Treatments: Understanding the Role of Vascular Calcification and Sclerostin Pathways

  • by Shuwei Weng, Chen Ding, Yuhong Shi, Hailin Zhang, Wenxiang Zhao, Jiang Zhu, Feng Peng, Dajun Chai

  • April 29, 2026

Related Content

Medical Oddities: Ancient Practice Calms Modern BP

Ancient workouts, anxious ears, tea gains, limb regrowth, and furry tongues collide.

MiR-1a-3p/Fcgr4-dependent osteoclast activation regulates pathological bone loss

MAFLD is associated with lower bone mineral density in patients with type 2 diabetes: an exploratory cross-sectional analysis of a potential indirect association with HOMA-IR